Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation
Clinical trial NCT03758677 · UNKNOWN
Trial details
- NCT number
- NCT03758677
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2020-11-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.